Publisher
Springer Berlin Heidelberg
Reference26 articles.
1. American College of Obstetricians and Gynecologists (2013) Committee opinion no. 556: Postmenopausal estrogen therapy: route of administration and risk of venous thromboembolism. Obstet Gynecol 121:887–890
2. AWMF Hormonal contraception. Guideline of the DGGG, SGGG and OEGGG (S3-Level, AW MF Registry No. 015/015, November 2019). http://www.awmf.org/leitlinien/detail/ll/015-015.html
3. WMF Peri- and Postmenopause – Diagnosis and Interventions. Guideline of the DGGG, SGGG and OEGGG (S3 Level, AW MF Registry No. 015-062, January 2020). https://www.awmf.org/leitlinien/detail/ll/015-062.html
4. de Bastos M, Stegeman BH, Rosendaal FR, Van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM (2014) Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD010813.pub2
5. Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY (2007) Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 115:840–845